Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study

This publication has 21 references indexed in Scilit:

• Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
  Nature Medicine, 2022
• Identifying and Alleviating Bias Due to Differential Depletion of Susceptible People in Postmarketing Evaluations of COVID-19 Vaccines
  American Journal of Epidemiology, 2022
• Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021
  Eurosurveillance, 2021
• Protective Behaviors Against COVID-19 by Individual Vaccination Status in 12 Countries During the Pandemic
  JAMA Network Open, 2021
• Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
  Nature Medicine, 2021
• Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021
  MMWR. Morbidity and Mortality Weekly Report, 2021
• Benefit of COVID-19 vaccination accounting for potential risk compensation
  npj Vaccines, 2021
• Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021
  Eurosurveillance, 2021
• The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data
  Clinical Infectious Diseases, 2021
• Factors associated with COVID-19-related death using OpenSAFELY
  Nature, 2020